Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study

A simple and rapid method using liquid chromatography–mass spectrometry (LC-MS) for the determination of metaxalone in human plasma has been developed and validated. Letrozole was used as the internal standard (IS). The plasma samples were simply treated with acetonitrile which allowed the precipita...

Full description

Bibliographic Details
Main Authors: Lanting Zhao, Qian Li, Chang Shu, Keli Wang, Li Ding
Format: Article
Language:English
Published: Elsevier 2016-10-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087616000052
_version_ 1818962425991397376
author Lanting Zhao
Qian Li
Chang Shu
Keli Wang
Li Ding
author_facet Lanting Zhao
Qian Li
Chang Shu
Keli Wang
Li Ding
author_sort Lanting Zhao
collection DOAJ
description A simple and rapid method using liquid chromatography–mass spectrometry (LC-MS) for the determination of metaxalone in human plasma has been developed and validated. Letrozole was used as the internal standard (IS). The plasma samples were simply treated with acetonitrile which allowed the precipitation of plasma proteins. The chromatographic separation was achieved on a Sapphire C18 (2.1 mm × 150 mm, 5 µm, Newark, USA) column using the mobile phase (5 mM ammonium acetate containing 0.01% formic acid: acetonitrile (45:55, v/v)) at a flow rate of 0.3 ml/min. The selected ion monitoring (SIM) in the positive mode was used for the determination of [M + H]+ m/z 222.1 and 286.1 for metaxalone and letrozole, respectively. The standard curve obtained was linear (r2 ≥ 0.99) over the concentration range of 30.24−5040 ng/ml. Meanwhile, no interfering peaks or matrix effect was observed. The method established was simple and successfully applied to a pharmacokinetic study of metaxalone in healthy Chinese volunteers after a single oral dose administration of 800 mg metaxalone. The main pharmacokinetic parameters of metaxalone were as follow: Cmax, (1664 ± 1208) ng/ml and (2063 ± 907) ng/ml; AUC0−36, (13925 ± 6590) ng/ml h and (18620 ± 5717) ng/ml h; t1/2, (13.6 ± 7.7) h and (20.3 ± 7.7) h for the reference and test tablets, respectively. These pharmacokinetic parameters of metaxalone in healthy Chinese volunteers were reported for the first time.
first_indexed 2024-12-20T12:29:08Z
format Article
id doaj.art-1b4e3b591bd840b79d6d27776026e2df
institution Directory Open Access Journal
issn 1818-0876
language English
last_indexed 2024-12-20T12:29:08Z
publishDate 2016-10-01
publisher Elsevier
record_format Article
series Asian Journal of Pharmaceutical Sciences
spelling doaj.art-1b4e3b591bd840b79d6d27776026e2df2022-12-21T19:40:46ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762016-10-0111566867210.1016/j.ajps.2016.01.002Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic studyLanting ZhaoQian LiChang ShuKeli WangLi DingA simple and rapid method using liquid chromatography–mass spectrometry (LC-MS) for the determination of metaxalone in human plasma has been developed and validated. Letrozole was used as the internal standard (IS). The plasma samples were simply treated with acetonitrile which allowed the precipitation of plasma proteins. The chromatographic separation was achieved on a Sapphire C18 (2.1 mm × 150 mm, 5 µm, Newark, USA) column using the mobile phase (5 mM ammonium acetate containing 0.01% formic acid: acetonitrile (45:55, v/v)) at a flow rate of 0.3 ml/min. The selected ion monitoring (SIM) in the positive mode was used for the determination of [M + H]+ m/z 222.1 and 286.1 for metaxalone and letrozole, respectively. The standard curve obtained was linear (r2 ≥ 0.99) over the concentration range of 30.24−5040 ng/ml. Meanwhile, no interfering peaks or matrix effect was observed. The method established was simple and successfully applied to a pharmacokinetic study of metaxalone in healthy Chinese volunteers after a single oral dose administration of 800 mg metaxalone. The main pharmacokinetic parameters of metaxalone were as follow: Cmax, (1664 ± 1208) ng/ml and (2063 ± 907) ng/ml; AUC0−36, (13925 ± 6590) ng/ml h and (18620 ± 5717) ng/ml h; t1/2, (13.6 ± 7.7) h and (20.3 ± 7.7) h for the reference and test tablets, respectively. These pharmacokinetic parameters of metaxalone in healthy Chinese volunteers were reported for the first time.http://www.sciencedirect.com/science/article/pii/S1818087616000052MetaxaloneLC-MSPharmacokinetics
spellingShingle Lanting Zhao
Qian Li
Chang Shu
Keli Wang
Li Ding
Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
Asian Journal of Pharmaceutical Sciences
Metaxalone
LC-MS
Pharmacokinetics
title Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
title_full Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
title_fullStr Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
title_full_unstemmed Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
title_short Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
title_sort quantitative determination of metaxalone in human plasma by lc ms and its application in a pharmacokinetic study
topic Metaxalone
LC-MS
Pharmacokinetics
url http://www.sciencedirect.com/science/article/pii/S1818087616000052
work_keys_str_mv AT lantingzhao quantitativedeterminationofmetaxaloneinhumanplasmabylcmsanditsapplicationinapharmacokineticstudy
AT qianli quantitativedeterminationofmetaxaloneinhumanplasmabylcmsanditsapplicationinapharmacokineticstudy
AT changshu quantitativedeterminationofmetaxaloneinhumanplasmabylcmsanditsapplicationinapharmacokineticstudy
AT keliwang quantitativedeterminationofmetaxaloneinhumanplasmabylcmsanditsapplicationinapharmacokineticstudy
AT liding quantitativedeterminationofmetaxaloneinhumanplasmabylcmsanditsapplicationinapharmacokineticstudy